Crossmark

Generation of iPSC lines (KAIMRCi003A, KAIMRCi003B) from a Saudi patient with Dravet syndrome carrying homozygous mutation in the CPLX1 gene and heterozygous mutation in SCN9A

Crossref DOI link: https://doi.org/10.1007/s13577-023-01016-z

Published Online: 2023-12-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Alowaysi, Maryam

Al-Shehri, Mohammad

Badkok, Amani

Attas, Hanouf

Aboalola, Doaa

Baadhaim, Moayad

Alzahrani, Hajar

Daghestani, Mustafa

Zia, Asima

Al-Ghamdi, Khalid

Al-Ghamdi, Asayil

Zakri, Samer

Aouabdi, Sihem

Tegner, Jesper

Alsayegh, Khaled https://orcid.org/0000-0003-2654-835X
Funding

Funding for this research was provided by:

Pfizer Pharmaceuticals
License Information

Text and Data Mining valid from 2023-12-19

Version of Record valid from 2023-12-19
More Information

Article History

Received: 26 September 2023

Accepted: 15 November 2023

First Online: 19 December 2023

Declarations

:

: The authors declare that they have no conflict of interest.

: This study was approved by the Institutional Review Board of King Abdullah International Medical Research Center (KAIMRC) (Protocol# RJ22J/060/03).

: Written informed consent was obtained from the study subjects.

Document is current

Any future updates will be listed below